Stealth BioTherapeutics Corp
Methods for the regulation of matrix metalloproteinase expression
Last updated:
Abstract:
The disclosure provides methods of reducing MMP-9 expression and/or MMP-9 activity in a mammalian subject. The disclosure also provides methods of increasing TIMP-1 expression and/or TIMP-1 activity in a mammalian subject. The methods comprise administering a therapeutically effective amount of an aromatic-cationic peptide to a subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
29 Jan 2018
Issue date:
7 Jan 2020